Takeda Pharmaceutical
TAK
#492
Rank
C$65.54 B
Marketcap
C$19.70
Share price
0.28%
Change (1 day)
3.67%
Change (1 year)

Earnings for Takeda Pharmaceutical (TAK)

Earnings in 2025 (TTM): C$2.77 Billion

According to Takeda Pharmaceutical's latest financial reports the company's current earnings are C$29.52 Billion. In 2024 the company made an earning of C$3.09 Billion a decrease over its 2023 earnings that were of C$3.16 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Takeda Pharmaceutical from 2009 to 2025

Annual earnings

Year Earnings Change
2025 (TTM) C$2.77 B-10.35%
2024 C$3.09 B-2.41%
2023 C$3.16 B-28.14%
2022 C$4.40 B-40.9%
2021 C$7.45 B78.24%
2020 C$4.18 B246.1%
2019 C$1.20 B-48.79%
2018 C$2.36 B-23.64%
2017 C$3.09 B21.7%
2016 C$2.54 B-253.01%
2015 -C$1.67 Billion-159.65%
2014 C$2.78 B13%
2013 C$2.46 B2.46%
2012 C$2.40 B-57.05%
2011 C$5.59 B-10.49%
2010 C$6.25 B-3.99%
2009 C$6.51 B

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Johnson & Johnson
JNJ
C$44.87 B 1,481.14%๐Ÿ‡บ๐Ÿ‡ธ USA
Sanofi
SNY
C$12.60 B 344.15%๐Ÿ‡ซ๐Ÿ‡ท France
Pfizer
PFE
C$16.41 B 478.46%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
C$22.74 B 701.36%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Seagen
SGEN
-C$1.1 Billion-138.59%๐Ÿ‡บ๐Ÿ‡ธ USA
Dr. Reddy's Laboratories
RDY
C$1.27 B-55.15%๐Ÿ‡ฎ๐Ÿ‡ณ India
Amgen
AMGN
C$11.41 B 302.36%๐Ÿ‡บ๐Ÿ‡ธ USA
GlaxoSmithKline
GSK
C$12.91 B 355.02%๐Ÿ‡ฌ๐Ÿ‡ง UK
Merck
MRK
C$31.98 B 1,026.95%๐Ÿ‡บ๐Ÿ‡ธ USA